O site do IMCAS tem um novo visual! Explore nosso site redesenhado. Estamos aqui para ajudá-lo a navegar pelos novos recursos e receber seu feedback em contact@imcas.com.
English
Español
Français
Português
Русский
简体中文
NANOPASS TECHNOLOGIES LTD
Israel
Site: https://micronjet.nanopass.com/
Número do estande: K216
Categorias da indústria
Perfil da empresa
NanoPass Technologies Ltd. is a pioneer in intradermal delivery, leveraging its proprietary MicronJet™ platform—the first FDA-cleared true intradermal delivery technology (<1 mm)—to transform treatments across both medical and aesthetic fields. With over 70 clinical studies and millions of successful procedures worldwide, the company is at the forefront of advancing vaccines, immunotherapies, and drug delivery, enabling proven dose-sparing and improved patient outcomes. In parallel, NanoPass has brought its innovation to the aesthetic landscape, where MicronJet™ provides physicians and patients with a new standard of safety, precision, and comfort—minimizing bruising, pain, and downtime while enabling consistent delivery of skin boosters, polynucleotides, PRP, and other intradermal treatments. Today, NanoPass operates globally in more than 30 countries, partnering with leading pharmaceutical and aesthetic brands.
Descubra IMCAS Academy
Precisa de ajuda?